Organigram Holdings Inc (CVE:OGI) CEO introduces Cutting-Edge Technology скачать в хорошем качестве

Organigram Holdings Inc (CVE:OGI) CEO introduces Cutting-Edge Technology

Organigram Holdings Inc (CVE:OGI) (OTCMKTS:OGRMF) (FRA:0OG) CEO Greg Engel discusses their strategic investment in Hyasynth Biologicals, Inc. Hyasynth have developed patent-pending technologies to engineer the precursor of cannabinoids from yeast which are ultimately converted into CBG, CBD, and THC compounds, identical to those found in the cannabis plant. Organigram believes the technology has massive potential to catalyze the marketplace by allowing the production of identical phytocannabinoids on a large scale at a low cost. The applications could be huge as companies move into producing more derivative-based cannabis products such as edibles and beverages. ************************ Check out our website: https://midasletter.com ************************ SUBSCRIBE to our YouTube: http://bit.ly/MidasLetterYoutube SUBSCRIBE to our Newsletter: http://bit.ly/MidasLetterNewsletter Download Our Podcast on iTunes: http://bit.ly/MidasLetterPodcast ************************ Follow Us on Twitter: http://bit.ly/MidasLetterTwitter Like Us on Instagram: http://bit.ly/MidasLetterInsta Like Us on Facebook: http://bit.ly/MidasLetterFacebook ************************